Navigation Links
Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
Date:12/6/2007

SOUTH SAN FRANCISCO, Calif., Dec. 6 /PRNewswire/ -- Raven biotechnologies, inc., a privately held company focused on the development of monoclonal antibody therapeutics (MAbs) for cancer, today announced that Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), has exercised an option to extend its evaluation of selected Raven MAb antibodies. As a result, Raven will receive an undisclosed milestone payment.

Under an agreement announced in January 2007, Wyeth has the option to obtain an exclusive license to develop and commercialize selected MAbs from Raven's portfolio of antibodies to a specified target.

The antibodies included in the agreement were discovered using Raven proprietary immunization technology and tumor-derived stem-cell lines and were screened to select antibodies that are active alone or in a conjugated form.

"We look forward to continuing our agreement with Wyeth, a company with a strong commitment to oncology research and development," said George F. Schreiner, M.D., Ph.D., Raven's Chief Executive Officer. "Raven has multiple anti-cancer antibody drug candidates in our pipeline, and collaborations such as this are a critical part of our strategy to rapidly advance the most promising candidates into the clinic."

About Raven

Raven biotechnologies, inc. (http://www.ravenbio.com) is a privately held biotechnology company focused on the development of monoclonal antibody therapeutics for treating cancer. Raven's lead product candidate, RAV12, targets adenocarcinomas and is in clinical development for the treatment of gastrointestinal and other cancers. Raven's discovery process simultaneously identifies cell-surface d
'/>"/>

SOURCE Raven biotechnologies, inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Positive Outcome of Drug-Drug Interaction Trial With Intravenous Iclaprim
2. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
3. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
4. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
5. Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
6. Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
7. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
8. Wyeth Announces Election of New Principal Corporate Officer
9. Wyeth Declares Preferred Stock Dividend
10. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
11. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... October 22, 2014 Grace Century, a ... healthcare projects, announces the addition of Dr. Yousef ... its advisory team. Dr. Siddiqui will provide further healthcare ... A graduate of University College Medical School ... in medicine in 2001. With further certification as a ...
(Date:10/22/2014)... According to new market research report ... Integration, Deployment & Support), by Service Model (SaaS, ... Others (Hybrid & Community)) - Global Forecast to ... Cloud Professional Services Market into various sub-segments with ... also identifies the drivers and restraints for this ...
(Date:10/22/2014)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... Oral Amphotericin B program.  The company recently announced ... work involving samples from HIV/AIDS patients exposed to ... clinical studies and regulatory filings to move forward ... approximately $700,000 of funding and technological advice from ...
(Date:10/22/2014)... DUBLIN , Oct. 22, 2014 ... "Organic Electronics Market by Material, by Application, Geography ... report to their offering. Organic electronics, ... a branch of material science which deals with small ... as organic because small molecules and polymers are carbon ...
Breaking Biology Technology:Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3
... Mike Byrom, Vince , Pallotta, ... 2130 Woodward Street Austin, TX 78744-1832 * Corresponding authors <A , ... href="mailto:lford@ambion.com">lford@ambion.com , ... , Labeling GAPDH and c-myc siRNA with either fluorescein ...
... Collections of siRNAs targeting , ... cells. To identify genes involved in ... cells can be transfected with different siRNAs and assayed for , ... Cellomics, Inc., who pioneered the field of High Content , ...
... Up to 50X more activity and 350% greater , catalytic efficiency ... DNA that can plague RT-PCR , ... origin: Purified from a source that is 10 7 -fold ... , , ...
Cached Biology Technology:Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 2Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 3Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 4Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 5Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 6Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 7Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 8Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 9Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 10Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 11Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 12Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 13Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 14Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 15Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 16Using Validated siRNAs in Functional Genomic Assays 2Using Validated siRNAs in Functional Genomic Assays 3TURBO DNase: Hyperactive, Salt Tolerant DNase 2TURBO DNase: Hyperactive, Salt Tolerant DNase 3TURBO DNase: Hyperactive, Salt Tolerant DNase 4TURBO DNase: Hyperactive, Salt Tolerant DNase 5
(Date:10/19/2014)... India over the last 30 years contributed only ... during that time, according to a new study ... ., "Energy access is fundamental to development: it ... education, communication, and health," says IIASA researcher Shonali ... energy access is widely agreed to be an ...
(Date:10/17/2014)... regarding Ebola is critical and pertinent for practicing physicians ... outbreak and epidemic. The Journal, Disaster Medicine and ... Ebola Virus and Public Health, to surround the public, ... critical societal moment. , On October 17, the ... . The primer was prepared by Dr. Eric Toner, ...
(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
Breaking Biology News(10 mins):Improved electricity access has little impact on climate change 2Modeling tumor dormancy 2
... When a zebra finch hears a new song from a member ... brain in unexpected ways, researchers report. The sequential switching on and ... tune offers a new picture of memory in the songbird brain. ... the National Academy of Sciences , was a surprise, said principal ...
... Institute,s Xie Lab has revealed how the BAM protein ... involved in regulating the quality of stem cells through ... Early Edition. Maintaining the proper balance between ... homeostasis. An imbalance between the two can lead to ...
... funded will serve aquaculture and papaya farmers as well ... species endangered due to attacks by several species of ... WPTRC, was awarded $186,960 for a genetic variability study ... vannamei, through developing a panel of species-specific microsatellite genetic ...
Cached Biology News:Researchers see evidence of memory in the songbird brain 2Xie Lab uncovers molecular machinery related to stem cell fate 2T-STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 2
... hormones which belong to the transforming ... superfamily is a large group of ... aspects of development, reproductive function and ... TGF-s, bone morphogenetic proteins, growth differentiation ...
... Antibody Plate is a 96-well ELISA-compatible ... This antibody (mouse IgG 1 ) ... glutathione-S-transferase (GST), and binds with ... fusion protein in which the tag ...
... Testing Laboratory (RTL) can provide you ... years. ,,Microbial method development and validation ... the conditions of your GMP manufacturing ... products,,We offer a full spectrum of ...
... QED Bioscience has over 23 years of ... lines. We have made antibodies to large ... and viral antigens, and plasmid DNA-encoded antigens. ... is unique, so our hybridoma development programs ...
Biology Products: